首页 | 本学科首页   官方微博 | 高级检索  
     

美金刚联合丁苯酞治疗血管性痴呆临床疗效观察
引用本文:潘蓉蓉,周龙寿,朱文宗,何金彩. 美金刚联合丁苯酞治疗血管性痴呆临床疗效观察[J]. 温州医学院学报, 2014, 0(10): 756-758
作者姓名:潘蓉蓉  周龙寿  朱文宗  何金彩
作者单位:1. 温州医科大学 第一临床医学院,浙江 温州 325035; 温州市中医院 老年病科,浙江 温州325000
2. 温州市中医院 老年病科,浙江 温州,325000
3. 温州医科大学附属第一医院 神经内科,浙江 温州,325015
摘    要:目的:观察美金刚(易倍申)和丁苯酞(恩必普)对血管性痴呆(Va D)患者认知和行为功能障碍的改善作用及安全性。方法:将40例Va D患者随机分为美金刚联合丁苯酞治疗组22例(联合治疗组)和美金刚治疗组18例(对照组)。2组患者分别在治疗前和治疗3个月、6个月进行简易精神状态检查(MMSE)以及日常生活能力(ADL)的测评,比较2组的评分结果,并观察不良反应。结果:联合治疗组患者3个月和6个月ADL评分分别为(25.2±5.4)分和(23.2±5.6)分,MMSE评分分别为(18.8±4.4)分和(20.1±4.8)分;对照组患者3个月和6个月ADL评分分别为(26.6±5.9)分和(25.4±6.1)分,MMSE评分分别为(18.1±4.9)分和(18.9±4.7)分。2组与治疗前相比差异均有统计学意义(均P〈0.05)。2组间治疗后6个月比较差异有统计学意义(P〈0.05)。2组均未出现严重不良反应。结论:美金刚和丁苯酞联合应用对Va D的认知功能、行为能力改善效果较单用美金刚明显,并具有较高的安全性。

关 键 词:美金刚  丁苯酞  血管性痴呆  简易精神状态检查  日常生活能力

Clinical research of combination of memantine and butylphthaliden in the treatment of patinta with vas- cular dementia
PAN Rongrong,ZHOU Longshou,ZHU Wenzong,HE Jincai. Clinical research of combination of memantine and butylphthaliden in the treatment of patinta with vas- cular dementia[J]. Journal of Wenzhou Medical College, 2014, 0(10): 756-758
Authors:PAN Rongrong  ZHOU Longshou  ZHU Wenzong  HE Jincai
Affiliation:PAN Rongrong, ZHOU Longshou,ZHU Wenzong, HE Jincai.( 1.The First Clinical Med- ical College of Wenzhou Medical University, Wenzhou, 325035; 2.Department of Geriatrics, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, 325000; 3.Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015)
Abstract:Objective: To observe the curative effect and safety of combination of memantine and bu-tylphthalide in the treatment of vascular dementia (VaD), the improvement of the cognitive function and behav- ioral capacity. Methods: Forty cases with VaD were randomly divided into 2 groups: one group treated with memantine and butylphthalide, the other group treated with memantine. MMSE scale and ADL scale of 2 groups were assessed and compared the pre-treatment with the treatment in 3 months, 6 months later. A comparative study was made to evalate the curative effects and side effects between 2 groups. Results: After treating with me- mantine and butylphthaliden for 3 months and 6 months, the ADL scores were (25.2±5.4) and (23.2±5.6) respec- tively, MMSE scores were (18.8±4.4) and (20.1±4.8) respectively. After treatment with memantine for 3 months and 6 months, the ADL scores were (26.6±5.9) and (25.4±6.1) respectively, MMSE scores were (18.1±4.9) and (18.9±4.7) respectively. The data compared pre-treatment with the two groups had statistical significance (P〈0.05). The scores of MMSE and ADL after 6 months treatment between two groups have statistical signifi- cance (P〈0.05). No serious adverse events was recorded during treatment. Conclusion: Combination of meman- tine and butylphthalide can markedly ameliorate the cognitive function and behavioral abilities in patients with vascular dementia. Its combination with butylphthalide is superior to its single use with high safety.
Keywords:memantine  butylphthalide  vascular dementia  MMSE  ADL
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号